Secretory carcinoma of the breast limited to the dermis: Cutaneous or breast primary?
ETV6-NTRK3
breast
carcinoma
secretory
skin
Journal
Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
revised:
13
05
2021
received:
23
01
2021
accepted:
30
05
2021
pubmed:
6
6
2021
medline:
1
2
2022
entrez:
5
6
2021
Statut:
ppublish
Résumé
We offer a case of a 22-year-old woman who presented with a painless breast mass. Physical examination of the breast was unrevealing other than a palpable mass in close proximity to the nipple areolar region. No lymphadenopathy was noticed in the axilla or supraclavicular region. Sonographic assessment was performed and the findings were classified as Breast Imaging Reporting and Data System category 4. Because of the proximity of the mass to the skin surface, an excisional biopsy was performed. Final pathology disclosed a 5-mm invasive carcinoma. On pathologic examination, histopathology and immunophenotyping supported the diagnosis of secretory carcinoma; however, whether the origin was from the breast parenchyma or skin tissue was not clearly discernable. Therefore, the patient was scheduled for sentinel lymph node biopsy with plans for axillary dissection if positive. While the overall prognosis for secretory carcinoma is good, with a low chance of metastasis, any ambiguity in breast mass diagnosis should be discussed in a multidisciplinary tumor board and should be treated aggressively particularly in younger patients.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1307-1310Informations de copyright
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Eusebi V, Ichihara S, Vincent-Salomon A. Exceptionally rare types and variants. In: Lakhani SR, Ellis IO, Schnitt SJ (eds.). WHO Classification of Tumours of the Breast. 4th edn. International Agency for Research on Cancer (IARC): Lyon, France, 2012, pp71-76.
Huang S, Liu Y, Su J, et al. “Secretory” carcinoma of the skin mimicking secretory carcinoma of the breast: case report and literature review. Am J Dermatopathol. 2016;38(9):698-703.
Lee SG, Jung SP, Lee HY, et al. Secretory breast carcinoma: a report of three cases and a review of the literature. Oncol Lett. 2014;8(2):683-686.
Bishop JA, Taube JM, Su A, et al. Secretory carcinoma of the skin harboring ETV6 gene fusions: a cutaneous analogue to secretory carcinomas of the breast and salivary glands. Am J Surg Pathol. 2017;41(1):62-66.
Moore RF, Cuda JD. Secretory carcinoma of the skin: case report and review of the literature. JAAD Case Rep. 2017;3(6):559-562.
Montalvo N, Galarza D, Redrobán L. Secretory Carcinoma of the parotid: making the correct diagnosis of a rare salivary gland carcinoma when molecular biology testing is not available. Case Reports in Pathol. 2019;2019:5103496.
Llamas-Velasco M, Mentzel T, Rütten A. Primary cutaneous secretory carcinoma: a previously overlooked low-grade sweat gland carcinoma. J Cutan Pathol. 2018;45(3):240-245.
Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2(5):367-376.
Skálová A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599-608.
Kastnerova L, Luzar B, Goto K, et al. Secretory carcinoma of the skin: report of 6 cases, including a case with a novel NFIX-PKN1 translocation. Am J Surg Pathol. 2019;43(8):1092-1098.
Li L, Wu N, Li F, Li L, Wei L, Liu J. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma. Cancer Biol Med. 2019;16(1):139-146.
Li D, Xiao X, Yang W, et al. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Mod Pathol. 2012;25(4):567-575.
Shui R, Cheng Y, Bai Q, Yang W. Secretory breast carcinoma with a papillary-predominant pattern: an unusual morphological variant. Histopathology. 2017;71(3):488-493.
Bell D, Ferrarotto R, Liang L, et al. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Virchows Arch. 2020;476(2):295-305.
Soyer T, Yaman Bajin İ, Orhan D, et al. Secretory breast carcinoma in a 6-year-old girl: mastectomy with sentinel lymph node dissection. Pediatr Surg Int. 2015;31(7):677-681.
Hoda RS, Brogi E, Pareja F, et al. Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential. Histopathology. 2019;75(2):213-224.
Horowitz DP, Sharma CS, Connolly E, Gidea-Addeo D, Deutsch I. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. Breast. 2012;21(3):350-353.
Anderson JL, Haidar YM, Armstrong WB, Tjoa T. Analysis of clinical features of mammary analog secretory carcinoma using the surveillance, epidemiology, and end results database. JAMA Otolaryngol Head Neck Surg. 2019;145(1):91-93.